Miloni Shah

Also affiliated with Clinical Research Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors”.

Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.01.006

N/A

0DataRank · unranked

13 citations

Christopher Su, Miriam M. Hu, Jeremy M. G. Taylor, Stephanie Daignault‐Newton, Olesia Kellezi +13 more

Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM)

CHEST Critical Care(2024)10.1016/j.chstcc.2024.100095

N/A

0DataRank · unranked

0 citations

Miloni Shah, Tatyana Der, Derek D. Cyr, Hussein R. Al‐Khalidi, Christopher J. Lindsell +10 more

Resource Utilization for COVID-19 Pneumonia in the ACTIV-1 Trial: A Secondary Data Analysis

UNC Libraries(2024)10.17615/stmd-4q47

N/A

0DataRank · unranked

0 citations

Derek D. Cyr, Miloni Shah, Anne M. Lachiewicz, Andreas Schmid, Martín Maillo +11 more